Caplin Point Laboratories Limited

Web: caplinpoint.net NSE: CAPLIPOINT BSE: 524742 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

2496 15(1%)

Near 52W High of 2699

Volume

2L as on 22, Jul

Open

2,042

High

2,609

Low

2,452

2,481

VWAP

2,516

52 Week High

2,699

52 Week Low

1,500

Viand Research Rating

Quality Score

69/100

Growth Score

45/100

Valuation Score

50/100

Momentum Score

50/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

18,969

No. of Shares

7.6

P/E

52.76

P/B

10.44

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

19.78

ROCE

Profit Growth

Listing Date

23-Jun-14

Promoter Holding

70.57%

FII Holding

6.15%

DII Holding

2.14%

Price Chart

Price Performance

1 Week6%

1 Month2%

3 Months42%

6 Months43%

1 Year18%

YTD38%

Moving Average

5 Day SMA2,605

10 Day SMA2,615

20 Day SMA2,586

30 Day SMA2,525

50 Day SMA2,321

61 Day SMA2,223

80 Day SMA2,090

200 Day SMA1,951

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	2,700	2,623	2,681	2,684
Resistance 2	2,681	2,618	2,660	2,673
Resistance 1	2,645	2,613	2,647	2,628
Pivot Point	2,625	2,608	2,625	2,617
Support 1	2,589	2,603	2,604	2,572
Support 2	2,569	2,598	2,591	2,561
Support 3	2,533	2,593	2,569	2,516

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,075	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,367	7284	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,71,221	5059	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,077	8838	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,13,284	1402	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,11,092	1114	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,480	2394	3%	3%	11%	25%	23	57.7	0.29	5355
8	MAXHEALTH	1,05,425	1083	2%	1%	8%	14%	0	57.7	0.32	1442
9	MANKIND	1,05,070	2544	0%	0%	18%	3%	49	57.7	0.39	1938
10	DRREDDY	97,179	1165	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 70.57%	(0.01) 70.57%	(0.01) 70.57%	(0.01) 70.56%	(0.01) 70.56%	(0.01) 70.56%	(0.01) 70.56%	(-0.11) 70.56%	(0.01) 70.62%	(0.01) 70.62%	(0.01) 70.62%	(0.01) 70.63%	(1.91) 70.66%	(-0.11) 68.80%	(0.01) 68.88%	(0.01) 68.88%	(0.01) 68.89%	(-0.11) 68.91%	(0.01) 69.03%
FIIs	(-0.41) 6.15%	(0.11) 6.58%	(0.41) 6.51%	(0.41) 6.16%	(0.91) 5.73%	(1.21) 4.86%	(0.31) 3.71%	(0.01) 3.38%	(0.51) 3.33%	(-0.31) 2.84%	(0.41) 3.09%	(0.31) 2.68%	(0.11) 2.36%	(0.11) 2.24%	(0.11) 2.15%	(0.01) 2.03%	(0.01) 2.07%	(0.41) 2.11%	(0.01) 1.76%
DIIs	(0.11) 2.14%	(-0.11) 2.05%	(-0.11) 2.10%	(0.21) 2.22%	(-0.11) 2.00%	(0.31) 2.11%	(0.31) 1.83%	(0.41) 1.49%	(0.71) 1.08%	(0.21) 0.43%	(-0.11) 0.21%	(-0.41) 0.27%	(-0.51) 0.64%	(0.01) 1.12%	(0.01) 1.12%	(-0.11) 1.12%	(0.01) 1.25%	(0.01) 1.22%	(0.01) 1.19%
Public	21.14%	20.81%	20.82%	21.06%	21.72%	22.48%	23.93%	24.59%	24.95%	26.11%	26.08%	26.44%	26.33%	27.84%	27.85%	27.97%	27.78%	27.76%	28.02%
No. of Shareholders	93,896	93,705	93,753	94,169	96,387	92,702	96,123	80,411	81,409	79,438	78,068	78,956	82,146	82,687	84,538	84,868	83,829	85,577	83,462

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	600	543	534	510	502	493	483	459	453	436	410	395	389	372	359	346	339	326	304	300
Sales Growth % (YoY)	19.4%	10.1%	10.5%	11.2%	10.9%	13.2%	17.8%	16.1%	16.4%	17%	14.2%	14.2%	14.8%	14.1%	18.3%	15.3%	21.7%	18.9%	13.2%	25.1%
Sales Growth % (QoQ)	10.5%	1.7%	4.7%	1.6%	1.8%	2.1%	5.2%	1.3%	3.9%	6.3%	3.8%	1.5%	4.6%	3.6%	3.8%	2.1%	4%	7.2%	1.3%	-
Expenses	396	353	345	332	334	331	318	307	308	293	273	269	265	263	253	244	239	225	202	208
Operating Profit	204	190	189	178	168	162	165	152	145	142	137	127	124	109	106	102	100	101	101	93
OPM %	34	35	35	35	33	33	34	33	32	33	34	32	32	29	29	30	29	31	33	31
Other Income	28	34	30	23	26	31	21	19	17	17	21	12	11	14	16	14	12	10	8	9
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	19	19	18	16	17	16	17	16	16	14	12	11	11	11	11	11	11	12	12	12
Profit before tax	213	204	201	184	177	177	168	154	146	145	146	127	124	112	110	105	100	99	98	90
Tax %	19	19	20	18	18	21	22	19	17	18	20	18	18	13	17	18	19	20	21	20
Net Profit	173	166	160	151	145	140	131	125	121	120	116	104	101	97	92	86	81	79	77	72
Net Profit Growth % (QoQ)	4.2%	3.8%	6%	4.1%	3.6%	6.9%	4.8%	3.3%	0.8%	3.4%	11.5%	3%	4.1%	5.4%	7%	6.2%	2.5%	2.6%	6.9%	-
Net Profit Growth % (YoY)	19.3%	18.6%	22.1%	20.8%	19.8%	16.7%	12.9%	20.2%	19.8%	23.7%	26.1%	20.9%	24.7%	22.8%	19.5%	19.4%	-	-	-	-
TTM Net Profit	650	622	596	567	541	517	497	482	461	441	418	394	376	356	338	323	309	228	149	0
EPS in Rs	22.38	21.56	20.32	20.1	18.76	18.28	17.21	16.31	16.01	15.43	15.13	13.62	13.45	12.84	12.09	11.21	10.43	9.89	9.91	9.37

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Jun 2015	Jun 2014	Jun 2013	Jan 1900
Sales	2187	1937	1694	1467	1269	1061	863	649	540	402	239	252	173	127	239
Sales Growth %	12.9%	14.4%	15.5%	15.5%	19.6%	23%	33.1%	20.2%	34.4%	68.2%	37.9%	45.5%	36.3%	18.5%	-
Expenses	1426	1287	1142	1025	874	732	603	417	345	276	175	192	137	105	175
Operating Profit	761	651	552	442	395	329	260	232	195	125	64	60	36	22	64
OPM %	35	34	33	30	31	31	30	36	36	31	27	24	21	18	27
Other Income	116	92	66	55	38	23	41	19	13	10	4	3	4	2	4
Interest	1	1	1	1	1	2	0	1	1	1	0	1	1	1	0
Depreciation	73	66	53	45	47	37	32	23	19	13	7	8	4	2	7
Profit before tax	803	677	564	451	386	314	269	227	188	121	60	53	36	22	60
Tax %	19	20	18	16	20	20	20	22	23	21	24	23	27	37	24
Net Profit	650	541	461	377	308	251	215	177	145	96	46	41	26	14	46
Net Profit Growth %	20.1%	17.4%	22.3%	22.4%	22.7%	16.7%	21.5%	22.1%	51%	108.7%	12.2%	57.7%	85.7%	-69.6%	-
EPS in Rs	84.36	70.56	60.19	49.57	39.56	32.03	28.42	23.35	19.15	12.65	6.05	5.43	3.42	1.85	6.05
Dividend Payout %	5	8	8	9	10	9	9	9	10	12	20	18	23	27	20

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Jun 2015	Jun 2014	Jun 2013
Cash from Operating Activity	523	432	318	271	337	269	45	83	66	68	42	50	60	32
Cash from Investing Activity	-582	-333	-319	-216	-377	-30	-54	-100	-69	-36	-6	-23	-44	-45
Cash from Financing Activity	-46	-38	-38	-28	-41	-24	80	90	-12	-7	-14	-9	-6	-1
Net Cash Flow	-106	61	-39	27	-81	215	70	73	-14	25	23	19	10	-15

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Jun 2015	Jun 2014	Jun 2013
Equity Capital	15	15	15	15	15	15	15	15	15	15	15	15	15	15	15	15
Reserves	3571	3144	2619	2527	2084	1649	1252	954	858	582	349	210	113	78	47	28
Borrowings	5	5	222	2	219	222	219	235	113	36	1	1	2	2	3	5
Other Liabilities	454	339	352	379	380	305	250	159	139	109	136	133	137	134	115	87
Total Liabilities	4045	3504	3208	2924	2698	2191	1736	1364	1126	743	500	358	267	229	180	135
Fixed Assets	605	555	546	465	453	280	287	305	272	227	169	152	144	113	102	33
CWIP	209	177	144	153	117	221	18	14	20	10	15	3	0	31	25	51
Investments	859	636	590	514	376	281	89	11	61	70	47	17	0	0	0	1
Other Assets	2373	2135	1928	1792	1753	1410	1343	1033	772	436	269	186	122	85	52	50
Total Assets	4045	3504	3208	2924	2698	2191	1736	1364	1126	743	500	358	267	229	180	135

Delivery

#	Date	1803 50% 2699	Value (Cr)	Q/T 11	Del 35	Del 29
1	22-Jul	2481	49	8	50	24
2	21-Jul	2608	14	7	57	8
3	20-Jul	2649	18	6	46	8
4	17-Jul	2614	19	5	54	10
5	16-Jul	2672	36	6	46	17
6	15-Jul	2648	25	8	38	9
7	14-Jul	2658	35	8	39	14
8	13-Jul	2616	19	6	42	8
9	10-Jul	2584	35	7	36	13
10	9-Jul	2621	31	8	46	14
11	8-Jul	2528	29	7	45	13
12	7-Jul	2567	26	7	47	12
13	6-Jul	2624	49	7	45	22
14	3-Jul	2538	32	7	33	10
15	2-Jul	2538	19	8	43	8
16	1-Jul	2564	24	7	46	11
17	30-Jun	2626	103	11	27	28
18	29-Jun	2558	54	9	43	24
19	25-Jun	2506	20	7	44	9
20	24-Jun	2519	56	8	24	13
21	23-Jun	2491	32	8	43	14
22	22-Jun	2537	40	7	40	16
23	19-Jun	2504	99	11	36	36
24	18-Jun	2359	13	6	41	5
25	17-Jun	2335	16	7	43	7
26	16-Jun	2378	24	8	36	9
27	15-Jun	2365	35	8	35	12
28	12-Jun	2408	54	10	35	19
29	11-Jun	2331	67	10	24	16
30	10-Jun	2309	204	12	20	40
31	9-Jun	2255	136	12	24	33
32	8-Jun	2111	133	13	23	30
33	5-Jun	2033	17	8	48	8
34	4-Jun	2020	20	9	54	11
35	3-Jun	1973	9	7	49	4
36	2-Jun	1988	15	8	53	8
37	1-Jun	1999	36	10	57	20
38	29-May	2024	20	9	48	10
39	27-May	2023	15	7	46	7
40	26-May	2036	23	12	45	10
41	25-May	2078	33	11	51	17
42	22-May	2028	18	8	45	8
43	21-May	2026	20	8	45	9
44	20-May	2017	36	10	43	15
45	19-May	2038	41	11	43	18
46	18-May	1986	37	10	37	14
47	15-May	1999	81	12	26	21
48	14-May	2024	453	17	12	54

Daily Market Cap

Date	Total Market Cap	Change	Chg %
23-Jul	18,970c	43c	0.22
22-Jul	18,927c	882c	4.45
21-Jul	19,809c	47c	0.24
17-Jul	19,856c	455c	2.24
16-Jul	20,310c	228c	1.14
15-Jul	20,082c	42c	0.21
14-Jul	20,041c	141c	0.71
13-Jul	19,900c	62c	0.31
10-Jul	19,961c	8c	0.04
09-Jul	19,953c	502c	2.58
08-Jul	19,451c	113c	0.58
07-Jul	19,564c	494c	2.46
06-Jul	20,058c	767c	3.98
02-Jul	19,291c	662c	3.32
30-Jun	19,953c	514c	2.64
29-Jun	19,439c	412c	2.17
26-Jun	19,027c	192c	1.02
25-Jun	18,835c	360c	1.88
24-Jun	19,195c	268c	1.42
23-Jun	18,927c	309c	1.60
22-Jun	19,236c	20c	0.10
19-Jun	19,216c	1,386c	7.77
17-Jun	17,830c	215c	1.19
16-Jun	18,045c	0	0
15-Jun	18,045c	312c	1.70
12-Jun	18,357c	515c	2.88
11-Jun	17,842c	116c	0.66
10-Jun	17,726c	0	0

Stock Checklist

Price is above from 52 week high low average: 66%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 70 fund scheme(s) across 19 fund house(s) as of Jul26 · Total value ₹526 Cr · 11 increasing / 2 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
UTI Mutual Fund	12	1.74%	-	481.7
Nippon India Mutual Fund	4	0.18%	-	12
Quantum Mutual Fund	2	1.79%	+0.71%	8.7
SBI Mutual Fund	4	0.10%	-	5.5
Motilal Oswal Mutual Fund	6	0.07%	-	4.9
HDFC Mutual Fund	6	0.11%	+0.07%	4.2
ICICI Prudential Mutual Fund	4	0.14%	+0.08%	3.6
ITI Mutual Fund	2	0.59%	-0.19%	3
Edelweiss Mutual Fund	2	0.18%	-	0.7
Jio BlackRock Mutual Fund	1	0.17%	-	0.6
Groww Mutual Fund	4	0.10%	-	0.5
Bandhan Mutual Fund	6	0.14%	-	0.4
Kotak Mahindra Mutual Fund	2	0.25%	+0.08%	0.3
Axis Mutual Fund	2	0.02%	-	0.1
Navi Mutual Fund	4	0.05%	-	0
DSP Mutual Fund	4	0.10%	-	0
Angel One Mutual Fund	2	0.02%	-	0
Mirae Asset Mutual Fund	2	0.02%	-	0
Zerodha Mutual Fund	1	0.12%	+0.03%	0

Caplin Point Laboratories Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements